Jarvis Hill

7PUBLICATIONS
12CO-AUTHORS
Haematological tumoursMolecular medicineMedical devicesMolecular targetsOrganic chemical synthesis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 17, 2026
Leveraging Homologous Recombination Deficiency via the Repositioned Prodrug CB1954.

|Sep 23, 2024
Computationally Driven Discovery of a BCR-ABL1 Kinase Inhibitor with Activity in Multidrug-Resistant Chronic Myeloid Leukemia.

Jarvis Hill, R Houston Givhan, Bin Yi

|Dec 20, 2023
Atypical N-Alkyl to N-Noralkoxy Switch in a Dual cSRC/BCR-ABL1 Kinase Inhibitor Improves Drug Efflux and hERG Affinity.

Jarvis Hill, Robert M Jones, David Crich

|Nov 07, 2023
Discovery of a Hydroxylamine-Based Brain-Penetrant EGFR Inhibitor for Metastatic Non-Small-Cell Lung Cancer.

Jarvis Hill, Robert M Jones, David Crich

|May 19, 2022
The N,N,O-Trisubstituted Hydroxylamine Isostere and Its Influence on Lipophilicity and Related Parameters.

Jarvis Hill, David Crich

|Jul 30, 2021
Synthesis of O-tert-Butyl-N,N-disubstituted Hydroxylamines by N-O Bond Formation.

Jarvis Hill, David Crich

Pageof 2

Frequent Collaborators

6 joint publications

David Crich

1 joint publications

Asiri A Hettikankanamalage

1 joint publications

Henry F Schaefer

1 joint publications

James L Elia